Wegovy vs Mounjaro: Mechanism & Switching Guide
Understanding How To Switch From Mounjaro To Wegovy: Key Differences
When considering how to switch from Mounjaro to Wegovy, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. This dual mechanism approach in Mounjaro may provide different appetite control patterns compared to Wegovy's singular GLP-1 focus. Some patients find they respond better to one mechanism over the other, making the switch a strategic decision based on individual response patterns.
The switching process requires careful clinical oversight, as both are prescription-only medicines requiring proper medical assessment. Your prescriber will evaluate your current Mounjaro response, any side effects experienced, and reasons for considering the change. The transition timeline varies depending on your current Mounjaro dose and individual tolerability, but typically involves a washout period before beginning Wegovy's dose escalation protocol. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which treatment aligns best with your weight management goals.
Wegovy Pricing For Patients Switching From Mounjaro
Understanding the cost implications when you switch from Mounjaro to Wegovy helps with treatment planning. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose at £209.99. New customers benefit from discount code FIRST40, whilst returning customers use DOSE25, both applied at checkout. Our Intro Duo bundle (0.25mg & 0.5mg) provides the first two months for £169.99, offering convenient supply continuity during your initial transition period.
For patients requiring extended starter phases when switching from Mounjaro, our Consistency bundles provide multiple pens of the same dose. The Consistency 0.25mg bundle offers two starter pens for £139.99, whilst the Consistency 0.5mg bundle provides two 0.5mg pens for £189.99. This flexibility proves particularly valuable when transitioning between treatments, as some patients benefit from extended time at lower doses. The Ultimate Stability Trio provides three 2.4mg maintenance pens for £649.99, ensuring uninterrupted supply once you've successfully transitioned and reached your optimal Wegovy dose.
Clinical Evidence Supporting Wegovy For Weight Management
The STEP clinical trial programme demonstrates Wegovy's efficacy in weight management, with patients achieving approximately 15% average weight loss at 68 weeks when used alongside a reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). The STEP 5 trial showed sustained weight loss of around 15.2% maintained at two years, indicating long-term treatment potential. For patients considering how to switch from Mounjaro to Wegovy, the SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, providing additional health benefits beyond weight management.
These clinical results support Wegovy as a robust weight management option, though individual responses vary between patients and treatments. The evidence base helps inform switching decisions, particularly when combined with your personal response history to Mounjaro. Your prescriber will consider both your Mounjaro treatment history and Wegovy's clinical profile to determine if switching aligns with your treatment goals and expected outcomes.
How Wegovy Works Compared To Mounjaro
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines that signals fullness to your brain. This mechanism reduces appetite, promotes earlier satiety after smaller meals, and may help reduce food cravings by acting on brain appetite centres. Unlike Mounjaro's dual GIP and GLP-1 approach, Wegovy focuses specifically on GLP-1 pathways, providing a more targeted mechanism that some patients find suits their physiology better. The once-weekly injection schedule maintains consistent hormone levels, supporting sustained appetite control throughout the week. Wegovy must be used alongside a reduced-calorie diet and increased physical activity to achieve optimal results, working as part of a comprehensive weight management approach rather than as a standalone solution.
Switching Process: From Assessment To Delivery
The process of how to switch from Mounjaro to Wegovy begins with our comprehensive 3-minute online clinical assessment, where you'll detail your current Mounjaro experience, response patterns, and reasons for considering the switch. Our prescriber team, working through our GPhC-registered pharmacy (#9012878), reviews your medical history and current treatment within 3 working days (or 24 hours with express service). Once approved, your Wegovy pen arrives via next-day delivery using our temperature-controlled cold-chain system, ensuring product integrity from our pharmacy to your door. The clinical team provides detailed switching guidance, including any recommended washout period and the appropriate starting dose based on your Mounjaro treatment history. This medically supervised approach ensures your transition between treatments follows best clinical practice whilst maintaining continuity in your weight management journey.
Storage Advantages When Switching To Wegovy
A practical advantage when you switch from Mounjaro to Wegovy involves storage flexibility, particularly relevant for travel or lifestyle considerations. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability provides greater flexibility for business travel, holidays, or situations where refrigeration access may be limited. The FlexTouch pen design offers intuitive injection experience with clear dose display and smooth injection mechanism. Before first use, store Wegovy in the fridge at 2-8°C, and follow the prescribed dose escalation schedule starting with 0.25mg for weeks 1-4, then progressing through each dose level as clinically appropriate. This storage advantage often influences patient preference when considering the switch from Mounjaro to Wegovy for lifestyle compatibility reasons.
Personalised Switching Strategy: Wegovy vs Mounjaro Considerations
Developing your personalised strategy for how to switch from Mounjaro to Wegovy involves evaluating several unique factors specific to your treatment experience. Some patients switch due to different side effect profiles between the medications, whilst others seek the storage convenience or prefer the singular GLP-1 mechanism over Mounjaro's dual approach. The injection frequency remains weekly for both treatments, but the dose progression differs, with Wegovy following a 5-step escalation protocol compared to Mounjaro's 6-step approach. Your switching timeline should account for any washout period recommended by your prescriber, typically allowing for complete clearance of tirzepatide before beginning semaglutide treatment.
Response patterns vary significantly between individuals, making the switching decision highly personal rather than universally applicable. Some patients find Wegovy's GLP-1-focused mechanism provides more predictable appetite control, whilst others may have responded better to Mounjaro's dual receptor approach. The clinical assessment process evaluates these individual factors, ensuring your switch from Mounjaro to Wegovy aligns with your specific treatment history, tolerance profile, and weight management objectives. Both treatments remain available from EverydayMeds, providing flexibility to optimise your prescription-only medicine choice with expert prescriber guidance.
Complete Your Wegovy Transition With Expert Support
Ready to explore how to switch from Mounjaro to Wegovy with professional clinical oversight? Our streamlined ordering process begins with your detailed clinical assessment, progresses through expert prescriber review, and concludes with secure next-day delivery of your prescribed Wegovy dose. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 for continued savings on their weight management treatment. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and explore our complete range of Wegovy options, from individual pens to convenient bundle packages. Our clinical team provides ongoing support throughout your transition, ensuring you receive optimal guidance when switching between these prescription-only medicines. Both Wegovy and Mounjaro remain available through our GPhC-registered pharmacy, giving you and your prescriber the flexibility to choose the most appropriate treatment for your individual circumstances and weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
